Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

RDYTAK

Dr. Reddy's Laboratories Limited

RDY · $13.21

55Fair

Takeda Pharmaceutical Company Limited

TAK · $20.21

63Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

RDY

55/100

TAK

63/100

Quality

Is it a profitable, well-run business?

RDY

1.8/10

TAK

2.1/10

Growth

Is the company growing?

RDY

2.7/10

TAK

4.5/10

Valuation

Is the price reasonable? (higher = cheaper)

RDY

4.9/10

TAK

6.9/10

Risk

How risky are the shares? (higher = lower risk)

RDY

7.8/10

TAK

6.9/10

Momentum

Is the share price trending up?

RDY

7.4/10

TAK

8.4/10

Financial strength

Is the balance sheet healthy?

RDY

6.6/10

TAK

2.8/10

The balanced view

Model-generated

Dr. Reddy's Laboratories Limited

This company has a mixed profile, with a relatively low-risk profile and a positive price trend, although its profitability is thin.

Leads on: risk, financial strength

Best feature: relatively low risk (Beta (vs. market): 0.25)

Watch out: profitability is thin (Return on invested capital (TTM): 5.8%)

Takeda Pharmaceutical Company Limited

This company scores above average, with supportive analyst views and a positive price trend, although its profitability is thin.

Leads on: quality, growth, valuation, momentum

Best feature: analysts broadly positive (Analyst buy share: 83%)

Watch out: profitability is thin (Return on equity (TTM): 2.4%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.